首页> 外文期刊>Cell and Tissue Research >The miRNA machinery in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases and benign melanocytic nevi
【24h】

The miRNA machinery in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases and benign melanocytic nevi

机译:原发性皮肤恶性黑色素瘤,皮肤恶性黑色素瘤转移和良性黑素细胞痣中的miRNA机制

获取原文
           

摘要

Although several studies have shown a dysregulation of microRNA (miRNA) expression profiles in cutaneous melanoma, there has been little research on the miRNA machinery itself. In this study, we investigated the mRNA expression profiles of different miRNA machinery components in primary cutaneous malignant melanoma (PCMM), cutaneous malignant melanoma metastases (CMMM) and benign melanocytic nevi (BMN). Patients with PCMM (n = 7), CMMM (n = 6) and BMN (n = 7) were included in the study. Punch biopsies were harvested from the centers of tumors (lesional) and from BMN (control). In contrast to previous reports exploring specific clusters of miRNAs in PCMM, the present study investigates mRNA expression levels of Dicer, Drosha, Exp5, DGCR8 and the RISC components PACT, argonaute-1, argonaute-2, TARBP1, TARBP2, MTDH and SND1, which were detected by TaqMan real-time reverse transcription polymerase chain reaction (RT-PCR). Argonaute-1, TARBP2 and SND1 expression levels were significantly higher in BMN compared to PCMM (p < 0.05). TARBP2 expression levels were significantly higher in CMMM compared to PCMM (p < 0.05). SND1 expression levels were significantly higher in CMMM compared to PCMM and BMN (p 0.05). The results of this study show that the miRNA machinery components argonaute-1, TARBP2 and SND1 are dysregulated in PCMM and CMMM compared to BMN and may play a role in the process of malignant transformation.
机译:尽管几项研究表明皮肤黑色素瘤中的microRNA(miRNA)表达谱失调,但对miRNA机制本身的研究很少。在这项研究中,我们调查了原发性皮肤恶性黑色素瘤(PCMM),皮肤恶性黑色素瘤转移瘤(CMMM)和良性黑素细胞痣(BMN)中不同miRNA机械成分的mRNA表达谱。研究包括PCMM(n = 7),CMMM(n = 6)和BMN(n = 7)患者。从肿瘤中心(病灶)和BMN(对照)收获拳打活检。与以前的报道探讨PCMM中特定miRNA簇的报道相比,本研究调查了Dicer,Drosha,Exp5,DGCR8和RISC成分PACT,argonaute-1,argonaute-2,TARBP1,TARBP2,MTDH和SND1的mRNA表达水平,通过TaqMan实时逆转录聚合酶链反应(RT-PCR)检测到。与PCMM相比,BMN中的Argonaute-1,TARBP2和SND1表达水平显着更高(p <0.05)。与PCMM相比,CMMM中的TARBP2表达水平显着更高(p <0.05)。与PCMM和BMN相比,CMMM中SND1表达水平显着更高(p 0.05)。这项研究的结果表明,与BMN相比,PCMM和CMMM中的miRNA机械成分argonaute-1,TARBP2和SND1失调,并且可能在恶性转化过程中起作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号